Approval · Notice of Compliance 28284 · 2022
NYDA: Notice of Compliance 28284
Issued May 30, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28284
- Date
- May 30, 2022
- Company
- G. Pohl-Boskamp GmbH & Co. KGHohenlockstedt, Schleswig-Holstein, Germany
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to packaging materials to comply with Plain Language Labelling (PLL) and revise the Product Monograph (PM) to 2020 format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NYDA | Not yet assigned | — |
Medicinal ingredients
- DIMETHICONE 50 PER